Skip to main content
Clinical Trials/NCT02413086
NCT02413086
Unknown
Not Applicable

Effectiveness and Safety of Early-Stage Amputation and External Herbs Chitosan for Diabetic Foot Ulcer

Heilongjiang University of Chinese Medicine0 sites320 target enrollmentApril 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetic Foot Ulcer
Sponsor
Heilongjiang University of Chinese Medicine
Enrollment
320
Primary Endpoint
The re-operation rate
Last Updated
11 years ago

Overview

Brief Summary

Diabetic Foot as the popular chronic complications of diabetes, is one of the main factors leading to limb amputation, it was reported that the amputation rate is 15 times of the non-diabetic patients. Common surgical amputation is not only about high plane amputation but also bring a tremendous mental stress to patients which may affect the quality of life seriously. Diabetic foot patients facing the great risk of serious infection, endotoxemia , and septic shock which could be the main cause of death before amputation. It become an important topic that how to control the infection, reduce the amputation plane, save the function as possibility, and improve the life quality of the patients as well.

This study is based on years of clinical experience of and brings out "early-stage amputation" concept firstly in China with a systematic exposition, experimental research and clinical research. Early-stage amputation refers to cut in the normal tissue from the inflammatory tissue at the junction line of limbs, in order to achieve more retained stump, block endotoxin absorption and improve the quality of life of patients. External therapy of herbs chitosan can promote granulation tissue regeneration and control of local infection, it solved the problem of difficult wound healing and it is a reliable guarantee of early-stage amputation.

Registry
clinicaltrials.gov
Start Date
April 2015
End Date
April 2018
Last Updated
11 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Sponsor
Heilongjiang University of Chinese Medicine
Responsible Party
Principal Investigator
Principal Investigator

Wang Kuanyu

Director of Department of Surgery, First Affiliated Hospital of Heilongjiang UCM

Heilongjiang University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • According to Chinese herbs medicine standard for the diagnosis and treatment of diabetic foot, the individual diagnosed as diabetic foot with acromelic gangrene.
  • The individual aged between 18 and 70 years.
  • All wounds corresponded to Wagner classification grade 4 or
  • By appropriate treatment, skin temperature of limb with ulcer became warmer and it proved that the blood circulation recovery could be happening.
  • There were no obvious bruises or chromatosis in the necrosis skin.
  • Persistent limb pain affected the sleep of the individuals.
  • The individual voluntarily signed the informed consent form.

Exclusion Criteria

  • Acromelic gangrene caused by other reasons.
  • The individuals with server cardiovascular and cerebrovascular diseases or hepatic and kidney diseases do not adhere to surgery.
  • The individuals with the history of amputation.
  • The individuals with systemic inflammatory response syndrome, Bacteremia, Pyemia or shock.
  • Vascular ultrasound shows artery is completely blocked.
  • The individuals do not adhere to the treatment or are with other treatments.

Outcomes

Primary Outcomes

The re-operation rate

Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.

Because of diabetic foot ulcer individual was given a re-operation.

Grades of wound healing

Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.

As wound healing, wound healing was assessed using 1 to 3 healing grades.

Secondary Outcomes

  • SF-36(7 days of amputation, 14 days of amputation, 1 month of amputation, 3 months of amputation and 6 months of amputation.)
  • Healing time(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.)
  • Amputation level(At time of surgery.)
  • The rate of infection(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.)
  • Trinity amputation and prosthesis experience scale (TAPES)(7 days of amputation, 14 days of amputation, 1 month of amputation, 3 months of amputation and 6 months of amputation.)

Similar Trials